维普中文期刊产品整合服务
21篇 您的检索式:作者名="HOGDALL C"
    题名 作者 年代 出处 被引量
1Evaluation of HFA, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass 显示文摘KARLSEN MA SANDHU N HOGDALL C 2012Gynecol Oncol2012,127,2:1
2Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma显示文摘Gronlund B Hansen HH Hogdall C 2002Cancer2002,95,8:1
3Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RE CIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma? 显示文摘Gronlund B Hogdall C Hilden J 2004J Clin Oncol2004,22,20:1
4YKL-40 tissue expression and plasma levels in patients with ovarian cancer显示文摘Hogdall E V Ringsholt M Hgdall C K 2009BMC Cancer2009,10,9:1
5Patients with atypical hyperplasia of the endometrium should be treated in oncological centers 显示文摘Antonsen SL Ulrich L Hogdall C 2012Gynecol Onco12012,125,1:1
6Influence of 2-(18F) fluo- ro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery显示文摘Risum S Hogdall C Markova EM 2009Int J Gynecol Cancer2009,19,4:1
7Evaluation of HE4,CA125,risk of ovarian malignancy algorithm(ROMA)and risk of malignancy index(RMI)as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass显示文摘Karisen MA Sandhu N Hogdall C 2012Gynecol Oncol2012,127,2:1
8Efficiency of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma显示文摘Gronlund B Hansen H Hogdall C 2002Cancer2002,95,:1
9YKL-40 tissue expres sion and plasma levels in patients with ovarian cancer 显示文摘HDgdall E V Ringsholt M Hogdall C K Christensen I J Johansen J S Kjaer S K 2009BMC Cancer2009,9,:1
10Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery显示文摘Risum S Hogdall C Markova EM 2009Int J Gynecol Cancer2009,19,4:1
11Efficiency of low dose topotecan in second line treatment for patients with epithelial ovarian carcinoma显示文摘Gronlund B Hansen HH Hogdall C 2002Cancer2002,95,8:1
12Evaluation of HE4, CA125,risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovari an cancer in patients with a pelvic mass显示文摘Karlsen MA Sandhu N Hogdall C 2012Gynecol Oncol2012,127,2:1
13The diagnostic value of PET/CT for primary ovarian cancer-a prospective study显示文摘Risum S Hogdall C Loft A 2007Gynecol Oncol2007,105,1:1
14The prognostic value of pre-operative serum tetranectin,CA-125 and a combined index in women with primary ovarian cancer显示文摘Hogdall C K Norgaard Pedersen B Mogensen O 2002Anticancer Res2002,22,3:1
15Limited prognostic value of tissue protein expression levels of eye- lin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study 显示文摘Heeran M C Hogdall C K Kjaer S K 2012APMIS2012,120,10:1
16Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass显示文摘Karlsen MA Sandhu N Hogdall C 2012Gynecol Oncol2012,127,2:1
17Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduetion in primary advanced ovarian cancer显示文摘RISUM S LOFT A HOGDALL C 2010Acta Oncol2010,57,3:1
18p53 Auto-antibodies in Sera from Danish Ovarian Cancer Patients and their Correlation with Clinical Data and Prognosis显示文摘Hogdall E V Hogdall C K Bladkaer J 2002APMIS2002,110,78:1
19Radiation therapy without cisplatin for elderly cervical cancer patients显示文摘Hansen H Hogdall C Engelholm S 2014Int J Radiat Oncol Biol Phys2014,90,:1
20Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography-a prospective study显示文摘Risum S Hogdall C Loft A 2008Gyneeol Oncol2008,108,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费